Target Up And Up Acne Spot Treatment Lotion
NDC Package 11673-149-51
Package Information
Target Up And Up Acne Spot Treatment (benzoyl peroxide) lotions is clean the skin thoroughly before applying this productCover the entire affected area with a thin layer one to three times dailyBecause excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctorIf bothersome dryness or peeling occurs, reduce application to once a day or every other dayIf going outside, apply sunscreen after using this product. This formulation utilizes a lotion delivery system. Marketed by Target Corporation, this product is identified by NDC 11673-149 and is authorized under FDA application M006.
Identification & Billing
- RxCUI: 200009 - benzoyl peroxide 2.5 % Topical Lotion
- RxCUI: 200009 - benzoyl peroxide 25 MG/ML Topical Lotion
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 11673 - Target Corporation
- 11673-149 - Target Up And Up Acne Spot Treatment
- 11673-149-51 - 1 TUBE in 1 CARTON / 21 g in 1 TUBE
- 11673-149 - Target Up And Up Acne Spot Treatment
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 11673-149-51 identifies a specific commercial package of 1 tube in 1 carton / 21 g in 1 tube of Target Up And Up Acne Spot Treatment, a human over the counter drug labeled by Target Corporation. This lotion is formulated for topical use and contains benzoyl peroxide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Target Corporation on September 13, 2016. The current certification is valid through December 31, 2027.
How is this Target Corporation product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 11673014951. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.